Quantcast

Latest Sanofi-Aventis Stories

2011-12-28 07:54:24

Although the U.S. Food and Drug Administration (FDA) has recommended that a certain type of genetic testing (for the genotype CYP2C19) be considered before prescribing the drug clopidogrel to identify individuals who may be less responsive to the medication, a review and analysis of previous studies did not find an overall significant association between the CYP2C19 genotype and cardiovascular events.

2011-12-06 14:00:00

GENE-MATRIX study to determine optimal antiplatelet therapy for 4,000 cardiac stent patients Ottawa, Ontario (PRWEB) December 06, 2011 Spartan Bioscience

89709824
2011-11-24 12:18:16

The FDA approved medication specifically designed for those who wake up in the middle of the night and can't fall back to sleep.